Detalhe da pesquisa
1.
Development of a Thalassemia International Prognostic Scoring System (TIPSS).
Blood Cells Mol Dis
; 99: 102710, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463683
2.
National networking in rare diseases and reduction of cardiac burden in thalassemia major.
Eur Heart J
; 43(26): 2482-2492, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907420
3.
Primary HBB gene mutation severity and long-term outcomes in a global cohort of ß-thalassaemia.
Br J Haematol
; 196(2): 414-423, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697800
4.
A complication risk score to evaluate clinical severity of thalassaemia syndromes.
Br J Haematol
; 192(3): 626-633, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216983
5.
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with ß-thalassemia.
Blood
; 133(12): 1279-1289, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617198
6.
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
Br J Haematol
; 191(1): 107-114, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32427352
7.
Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors.
Ann Hematol
; 99(6): 1209-1215, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32363417
8.
Urinary Metabolic Profile of Patients with Transfusion-Dependent ß-Thalassemia Major Undergoing Deferasirox Therapy.
Kidney Blood Press Res
; 45(3): 455-466, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434200
9.
Long-term improvement in cardiac magnetic resonance in ß-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function.
Am J Hematol
; 94(3): 312-318, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30489651
10.
The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
Br J Haematol
; 180(5): 721-726, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363758
11.
Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.
Eur J Haematol
; 100(2): 124-130, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29094403
12.
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Br J Haematol
; 176(1): 124-130, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27748513
13.
Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
Ann Hematol
; 96(9): 1541-1546, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28707012
14.
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years.
Br J Clin Pharmacol
; 83(3): 593-602, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641003
15.
Risk of mortality from anemia and iron overload in nontransfusion-dependent ß-thalassemia.
Am J Hematol
; 97(2): E78-E80, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862982
16.
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.
Am J Hematol
; 92(12): 1349-1355, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28929515
17.
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.
Am J Hematol
; 97(2): E75-E78, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861054
18.
The long-term and extensive efficacy of low dose thalidomide in a case of an untransfusable patient with Non-Transfusion-Dependent Thalassemia.
Blood Cells Mol Dis
; 57: 97-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26810455
19.
Survival and causes of death in 2,033 patients with non-transfusion-dependent ß-thalassemia
Haematologica
; 106(9): 2489-2492, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882642
20.
Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity.
Ann Hematol
; 100(7): 1907-1910, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851259